Adcock Ingram Holdings Limited

Adcock Ingram Holdings Limited, a South Africa-based pharmaceutical preparation manufacturer, reported total carbon emissions of approximately 131.47 million kg CO2e in 2024. This figure includes Scope 1 emissions of around 17.23 million kg CO2e, Scope 2 emissions of about 52.56 million kg CO2e, and Scope 3 emissions of approximately 63.53 million kg CO2e. Key contributors to Scope 1 emissions were stationary combustion (12.60 million kg CO2e) and fugitive emissions (4.38 million kg CO2e). Scope 2 emissions were primarily from purchased electricity (50.72 million kg CO2e). Within Scope 3, significant categories included purchased goods and services (21.28 million kg CO2e), upstream transportation and distribution (17.12 million kg CO2e), and fuel and energy-related activities (15.88 million kg CO2e).

In the preceding year, 2023, the company's reported total emissions were approximately 134.03 million kg CO2e. This comprised about 21.22 million kg CO2e from Scope 1 and 60.33 million kg CO2e from Scope 3, with employee commute accounting for 3.16 million kg CO2e within Scope 3.

Adcock Ingram Holdings Limited has not publicly disclosed specific carbon emission reduction targets or commitments such as SBTi targets or participation in the Climate Pledge.